Dr. Caldera is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1685 Highland Ave
# 4256
Madison, WI 53705Phone+1 608-263-1995
Summary
- Dr. Caldera specializes in the care and treatment of patients with inflammatory bowel disease, Crohn's Disease and ulcerative colitis.
Education & Training
- University of Kentucky College of MedicineFellowship, Gastroenterology, 2008 - 2011
- University of Kentucky College of MedicineResidency, Internal Medicine, 2005 - 2008
- Des Moines University College of Osteopathic MedicineClass of 2004
Certifications & Licensure
- WI State License 2011 - 2025
- KY State License 2008 - 2012
- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Improving Knowledge of Medication in Ulcerative Colitis With an Iphone Application Start of enrollment: 2014 Feb 01
Publications & Presentations
PubMed
- 11 citationsSafety of Immunizations for the Adult Patient With Inflammatory Bowel Disease-A Systematic Review and Meta-analysis.Athanasios Desalermos, Michael Pimienta, Markos Kalligeros, Fadi Shehadeh, Leonidas Nikolaos Diamantopoulos
Inflammatory Bowel Diseases. 2021-11-24 - 16 citationsThe Development and Initial Findings of A Study of a Prospective Adult Research Cohort with Inflammatory Bowel Disease (SPARC IBD).Laura E. Raffals, Sumona Saha, Meenakshi Bewtra, Cecile Norris, Angela Dobes
Inflammatory Bowel Diseases. 2021-08-26 - 5 citationsOptimizing Immunization Strategies in Adult Patients With Chronic Liver Disease and Liver Transplant Recipients.Stacey Rolak, Adnan Said, Rita German, Mary S Hayney, Freddy Caldera
Gastroenterology & Hepatology. 2022-04-01
Journal Articles
- Immunosuppression Does Not Affect Antibody Concentrations to Measles, Mumps, and Rubella in Patients with Inflammatory Bowel DiseaseMark Reichelderfer, Arnold Wald, Jeffrey Hubers, Freddy Caldera, Sumona Saha, Elizabeth Ann Misch, Mary S Hayney, Digestive Diseases and Sciences
Press Mentions
- Breakthrough COVID-19 Milder in Vaccinated Patients with IBDFebruary 14th, 2022
- COVID-19 Vaccine Booster Benefits ‘Outweigh Risks’ Among ImmunocompromisedNovember 22nd, 2021
- UW Study Finds Most Patients with Inflammatory Bowel Disease Have Immune Response to COVID-19 Vaccine; Expands EnrollmentSeptember 8th, 2021
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: